The France Info feature reflects a growing international curiosity about how the United States is handling a wave of new GLP-1-based medications such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro)
To get the full picture of how peptides are changing the game, check out our comprehensive guide on peptide solutions
Nat Commun 15 , 6152 (2024)
ACR Biostatistician Laura Gillis, PhD, served as the study statistician
During the opening lecture at the International Conference on Advanced Technologies & Treatments for Diabetes, Melanie Davies, CBE, MB, ChB, MD, FRCP, FRCGP, professor of diabetes medicine at the University of Leicester and an honorary consultant diabetologist at the University Hospitals of Leicester NHS Trust, reviewed how GLP-1 receptor agonists such as semaglutide (Ozempic/Wegovy, Novo Nordisk) have changed the way providers approach the treatment of type 2 diabetes and obesity and discussed some of the medications that combine GLP-1 with other molecules
However, the precise regulatory mechanisms of cell death in this process require further investigation (212)